Founded with a mission to address inefficiencies in the US healthcare system, Kalderos focuses on increasing transparency and restoring trust among healthcare providers, drug manufacturers, payers, and government agencies. The company's core product is its Drug Discount Management platform, which leverages extensive drug discount data to provide clarity and prevent noncompliant discounts. By streamlining the process, Kalderos aims to reduce the overall cost of healthcare and allow stakeholders to concentrate on improving patient outcomes.
Kalderos has garnered attention from notable investors and industry leaders for its innovative approach to solving drug discount dysfunction. The platform's ability to manage and clarify drug discount data has led to significant cost savings and operational efficiencies within the healthcare ecosystem. As a result, Kalderos has made a substantial impact on reducing misapplied drug discounts, ultimately contributing to a more transparent and trustworthy healthcare system.